Sylvamo (SLVM) Financials

$38.69 +0.43 (+1.12%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$38.70 +0.01 (+0.03%)

As of 05/14/2026 04:10 PM Eastern

Annual Income Statements for Sylvamo

This table shows Sylvamo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	377	170	331	118	253	302	132
Consolidated Net Income / (Loss)	377	170	331	118	253	302	132
Net Income / (Loss) Continuing Operations	377	87	227	336	253	302	132
Total Pre-Tax Income	502	95	328	467	369	405	199
Total Operating Income	493	91	327	536	403	444	238
Total Gross Profit	1,379	456	685	1,009	912	940	735
Total Revenue	4,017	2,385	2,828	3,628	3,721	3,773	3,351
Operating Revenue	4,017	2,385	2,828	3,628	3,721	3,773	3,351
Total Cost of Revenue	2,638	1,929	2,143	2,619	2,809	2,833	2,616
Operating Cost of Revenue	2,638	1,929	2,143	2,619	2,809	2,833	2,616
Total Operating Expenses	886	365	358	473	509	496	497
Selling, General & Admin Expense	655	202	207	325	343	311	281
Depreciation Expense	192	135	126	125	143	159	179
Other Operating Expenses / (Income)	33	28	25	23	23	26	26
Impairment Charge	-	-	-	-	0.00	0.00	11
Total Other Income / (Expense), net	9.00	4.00	1.00	-69	-34	-39	-39
Interest Expense	-9.00	-4.00	-1.00	69	34	39	39
Income Tax Expense	125	8.00	101	131	116	103	67
Basic Earnings per Share	$8.55	$3.85	$7.53	$2.68	$6.02	$7.35	$3.29
Weighted Average Basic Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Diluted Earnings per Share	$8.55	$3.85	$7.53	$2.66	$5.93	$7.18	$3.24
Weighted Average Diluted Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Weighted Average Basic & Diluted Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Cash Dividends to Common per Share	-	-	-	$0.48	$1.40	$1.65	$1.80

This table shows Sylvamo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	58	49	43	83	95	81	27	15	57	33	-3.00
Consolidated Net Income / (Loss)	58	49	43	83	95	81	27	15	57	33	-3.00
Net Income / (Loss) Continuing Operations	58	49	43	83	95	81	27	15	57	33	-3.00
Total Pre-Tax Income	91	67	60	113	132	100	33	20	88	58	-6.00
Total Operating Income	100	73	69	122	146	107	42	30	97	69	3.00
Total Gross Profit	232	211	189	249	265	237	159	154	222	200	125
Total Revenue	897	964	905	933	965	970	821	794	846	890	755
Operating Revenue	897	964	905	933	965	970	821	794	846	890	755
Total Cost of Revenue	665	753	716	684	700	733	662	640	624	690	630
Operating Cost of Revenue	665	753	716	684	700	733	662	640	624	690	630
Total Operating Expenses	132	138	120	127	119	130	117	124	125	131	122
Selling, General & Admin Expense	89	96	74	82	74	81	73	72	68	68	73
Depreciation Expense	36	38	39	37	39	44	40	45	49	45	41
Other Operating Expenses / (Income)	7.00	4.00	7.00	8.00	6.00	5.00	4.00	7.00	8.00	7.00	8.00
Total Other Income / (Expense), net	-9.00	-6.00	-9.00	-9.00	-14	-7.00	-9.00	-10	-9.00	-11	-9.00
Interest Expense	9.00	6.00	9.00	9.00	14	7.00	9.00	10	9.00	11	9.00
Income Tax Expense	33	18	17	30	37	19	6.00	5.00	31	25	-3.00
Basic Earnings per Share	$1.39	$1.19	$1.04	$2.02	$2.32	$1.97	$0.66	$0.37	$1.43	$0.83	($0.08)
Weighted Average Basic Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Diluted Earnings per Share	$1.37	$1.17	$1.02	$1.98	$2.27	$1.91	$0.65	$0.37	$1.41	$0.81	($0.08)
Weighted Average Diluted Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Weighted Average Basic & Diluted Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Cash Dividends to Common per Share	$0.60	-	$0.30	$0.45	$0.45	-	$0.45	$0.45	$0.45	-	$0.45

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-40	-40	89	201	-80	-75	-70
Net Cash From Operating Activities	524	359	549	438	504	469	268
Net Cash From Continuing Operating Activities	524	245	423	418	504	469	268
Net Income / (Loss) Continuing Operations	377	87	227	336	253	302	132
Consolidated Net Income / (Loss)	377	-	-	-	253	302	132
Depreciation Expense	192	135	126	125	143	159	179
Non-Cash Adjustments To Reconcile Net Income	19	36	14	41	23	23	29
Changes in Operating Assets and Liabilities, net	-64	-11	56	-63	85	-15	-72
Net Cash From Investing Activities	-160	-79	127	180	-377	-221	-224
Net Cash From Continuing Investing Activities	-160	-68	113	185	-377	-221	-224
Purchase of Property, Plant & Equipment	-118	-66	-69	-149	-210	-221	-224
Acquisitions	-	-	0.00	0.00	-167	0.00	0.00
Net Cash From Financing Activities	-387	-350	-589	-470	-219	-310	-125
Net Cash From Continuing Financing Activities	-387	-350	-588	-469	-219	-310	-125
Repayment of Debt	-18	-10	-113	-454	-538	-429	-199
Repurchase of Common Equity	-	0.00	0.00	-80	-70	-69	-82
Payment of Dividends	-	0.00	0.00	-10	-57	-62	-73
Issuance of Debt	0.00	0.00	1,501	75	446	250	229
Effect of Exchange Rate Changes	-17	30	-2.00	32	12	-13	11

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	90	26	-71	-4.00	103	-103	-51	-41	-19	41	-5.00
Net Cash From Operating Activities	197	167	27	115	163	164	23	64	87	94	-10
Net Cash From Continuing Operating Activities	197	167	27	115	163	164	23	64	87	94	-10
Net Income / (Loss) Continuing Operations	58	49	43	83	95	81	27	15	57	33	-3.00
Consolidated Net Income / (Loss)	58	-	43	83	95	-	27	15	57	33	-3.00
Depreciation Expense	36	38	39	37	39	44	40	45	49	45	41
Non-Cash Adjustments To Reconcile Net Income	6.00	2.00	7.00	5.00	5.00	6.00	6.00	7.00	4.00	12	-16
Changes in Operating Assets and Liabilities, net	97	78	-62	-10	24	33	-50	-3.00	-23	4.00	-32
Net Cash From Investing Activities	-42	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49
Net Cash From Continuing Investing Activities	-42	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49
Purchase of Property, Plant & Equipment	-42	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49
Net Cash From Financing Activities	-58	-88	-35	-60	-19	-196	-31	-45	-52	3.00	53
Net Cash From Continuing Financing Activities	-58	-88	-35	-60	-19	-196	-31	-45	-52	3.00	53
Repayment of Debt	-40	-49	-24	-32	-235	-138	-16	-32	-10	-141	-43
Repurchase of Common Equity	-13	-17	-5.00	-25	-	-39	-20	-20	-42	-	0.00
Payment of Dividends	-11	-25	-12	-13	-18	-19	-18	-18	-19	-18	-18
Issuance of Debt	6.00	3.00	6.00	10	234	-	23	25	19	162	114
Effect of Exchange Rate Changes	-7.00	10	-3.00	-6.00	3.00	-7.00	5.00	6.00	-	-	1.00

This table presents Sylvamo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	2,911	2,597	2,710	2,872	2,604	2,763
Total Current Assets	1,119	1,108	1,243	1,193	1,063	1,076
Cash & Equivalents	95	159	360	220	205	135
Note & Lease Receivable	621	402	450	428	429	424
Inventories, net	342	279	364	404	361	418
Other Current Assets	61	89	69	81	68	99
Plant, Property, & Equipment, net	0.00	0.00	817	0.00	0.00	0.00
Total Noncurrent Assets	1,792	1,489	650	1,679	1,541	1,687
Goodwill	143	122	128	139	111	114
Other Noncurrent Operating Assets	1,649	1,226	522	1,540	1,430	1,573
Total Liabilities & Shareholders' Equity	2,911	2,597	2,710	2,872	2,604	2,763
Total Liabilities	799	2,415	2,032	1,971	1,757	1,797
Total Current Liabilities	490	758	728	695	682	716
Short-Term Debt	4.00	41	29	28	22	90
Accounts Payable	284	387	453	421	375	381
Current Employee Benefit Liabilities	68	48	81	63	79	55
Other Current Liabilities	134	191	165	183	206	190
Total Noncurrent Liabilities	309	1,657	1,304	1,276	1,075	1,081
Long-Term Debt	22	1,357	1,003	931	782	763
Noncurrent Deferred & Payable Income Tax Liabilities	170	169	183	189	152	175
Other Noncurrent Operating Liabilities	117	118	118	156	141	143
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,112	182	678	901	847	966
Total Preferred & Common Equity	2,112	182	678	901	847	966
Total Common Equity	2,112	182	678	901	847	966
Common Stock	0.00	48	69	93	116	135
Retained Earnings	0.00	1,935	2,029	2,222	2,455	2,514
Treasury Stock	-	0.00	-82	-	-234	-330
Accumulated Other Comprehensive Income / (Loss)	-1,480	-1,801	-1,338	-1,256	-1,490	-1,353

This table presents Sylvamo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	2,798	2,823	2,785	2,797	2,691	2,861	2,629	2,668	2,703	2,834
Total Current Assets	1,209	1,161	1,186	1,115	1,100	1,229	1,011	977	990	1,097
Cash & Equivalents	191	164	194	149	145	248	154	113	94	130
Note & Lease Receivable	441	440	423	413	411	439	416	383	393	378
Inventories, net	506	486	456	407	412	421	372	396	434	483
Other Current Assets	71	71	53	86	72	61	69	85	69	106
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	1,589	1,662	1,599	1,682	1,591	1,632	1,618	1,691	1,713	1,737
Goodwill	133	140	134	134	121	125	119	126	128	121
Other Noncurrent Operating Assets	1,456	1,522	1,465	1,548	1,470	1,507	1,499	1,565	1,585	1,616
Total Liabilities & Shareholders' Equity	2,798	2,823	2,785	2,797	2,691	2,861	2,629	2,668	2,703	2,834
Total Liabilities	2,008	1,961	1,949	1,908	1,861	1,924	1,721	1,709	1,726	1,855
Total Current Liabilities	726	667	674	649	654	714	616	635	653	758
Short-Term Debt	104	79	53	28	28	43	23	46	30	155
Accounts Payable	409	391	382	404	389	381	386	371	383	407
Current Employee Benefit Liabilities	53	50	66	52	65	76	52	53	57	56
Other Current Liabilities	160	147	173	165	172	214	155	165	183	140
Total Noncurrent Liabilities	1,282	1,294	1,275	1,259	1,207	1,210	1,105	1,074	1,073	1,097
Long-Term Debt	954	954	946	921	894	883	794	767	778	766
Noncurrent Deferred & Payable Income Tax Liabilities	198	212	202	180	162	164	162	151	148	179
Other Noncurrent Operating Liabilities	130	128	127	158	151	163	149	156	147	152
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	790	862	836	889	830	937	908	959	977	979
Total Preferred & Common Equity	790	862	836	889	830	937	908	959	977	979
Total Common Equity	790	862	836	889	830	937	908	959	977	979
Common Stock	76	84	90	99	105	110	123	130	134	139
Retained Earnings	2,116	2,153	2,185	2,253	2,317	2,393	2,463	2,460	2,499	2,493
Treasury Stock	-	-	-141	-170	-195	-195	-268	-288	-330	-336
Accumulated Other Comprehensive Income / (Loss)	-1,305	-1,248	-1,298	-1,293	-1,397	-1,371	-1,410	-1,343	-1,326	-1,317

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	-40.63%	18.57%	28.29%	2.56%	1.40%	-11.18%
EBITDA Growth	0.00%	-67.01%	100.44%	45.92%	-17.40%	10.44%	-30.85%
EBIT Growth	0.00%	-81.54%	259.34%	63.91%	-24.81%	10.17%	-46.40%
NOPAT Growth	0.00%	-77.49%	171.56%	70.41%	-28.35%	19.82%	-52.32%
Net Income Growth	0.00%	-54.91%	94.71%	-64.35%	114.41%	19.37%	-56.29%
EPS Growth	0.00%	-54.97%	95.58%	-64.67%	122.93%	21.08%	-54.87%
Operating Cash Flow Growth	0.00%	-31.49%	52.92%	-20.22%	15.07%	-6.94%	-42.86%
Free Cash Flow Firm Growth	0.00%	0.00%	154.31%	-77.39%	-80.76%	904.24%	-117.23%
Invested Capital Growth	0.00%	0.00%	-41.02%	12.03%	17.04%	-8.48%	16.46%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	15.25%	1.00%	0.16%	-2.33%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	29.35%	-9.75%	7.10%	-8.15%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	34.34%	-14.07%	8.29%	-13.77%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	44.54%	-14.45%	11.26%	-23.42%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	37.21%	-15.10%	11.85%	-26.67%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-13.81%	11.49%	-25.35%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	7.02%	-6.01%	5.22%	-0.64%	-20.71%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	103.68%	43.73%	-214.24%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-0.06%	-7.01%	-0.41%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	34.33%	19.12%	24.22%	27.81%	24.51%	24.91%	21.93%
EBITDA Margin	17.05%	9.48%	16.02%	18.22%	14.67%	15.98%	12.44%
Operating Margin	12.27%	3.82%	11.56%	14.77%	10.83%	11.77%	7.10%
EBIT Margin	12.27%	3.82%	11.56%	14.77%	10.83%	11.77%	7.10%
Profit (Net Income) Margin	9.39%	7.13%	11.70%	3.25%	6.80%	8.00%	3.94%
Tax Burden Percent	75.10%	178.95%	100.91%	25.27%	68.56%	74.57%	66.33%
Interest Burden Percent	101.83%	104.40%	100.31%	87.13%	91.56%	91.22%	83.61%
Effective Tax Rate	24.90%	8.42%	30.79%	28.05%	31.44%	25.43%	33.67%
Return on Invested Capital (ROIC)	0.00%	8.16%	13.94%	30.19%	18.86%	21.88%	10.09%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-243.04%	35.88%	-1.39%	15.41%	17.33%	6.16%
Return on Net Nonoperating Assets (RNNOA)	0.00%	7.94%	14.92%	-2.75%	13.18%	12.67%	4.47%
Return on Equity (ROE)	0.00%	16.10%	28.86%	27.44%	32.05%	34.55%	14.56%
Cash Return on Invested Capital (CROIC)	0.00%	-191.84%	65.54%	18.84%	3.16%	30.74%	-5.12%
Operating Return on Assets (OROA)	0.00%	3.13%	11.87%	20.20%	14.44%	16.22%	8.87%
Return on Assets (ROA)	0.00%	5.84%	12.02%	4.45%	9.06%	11.03%	4.92%
Return on Common Equity (ROCE)	0.00%	16.10%	28.86%	27.44%	32.05%	34.55%	14.56%
Return on Equity Simple (ROE_SIMPLE)	0.00%	8.05%	181.87%	17.40%	28.08%	35.66%	0.00%
Net Operating Profit after Tax (NOPAT)	370	83	226	386	276	331	158
NOPAT Margin	9.22%	3.49%	8.00%	10.63%	7.43%	8.78%	4.71%
Net Nonoperating Expense Percent (NNEP)	0.00%	251.20%	-21.95%	31.58%	3.45%	4.55%	3.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	22.55%	14.86%	20.05%	8.68%
Cost of Revenue to Revenue	65.67%	80.88%	75.78%	72.19%	75.49%	75.09%	78.07%
SG&A Expenses to Revenue	16.31%	8.47%	7.32%	8.96%	9.22%	8.24%	8.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.06%	15.30%	12.66%	13.04%	13.68%	13.15%	14.83%
Earnings before Interest and Taxes (EBIT)	493	91	327	536	403	444	238
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	685	226	453	661	546	603	417
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	6.40	2.98	2.20	3.80	1.95
Price to Tangible Book Value (P/TBV)	0.00	0.00	19.42	3.67	2.60	4.38	2.21
Price to Revenue (P/Rev)	0.00	0.00	0.41	0.56	0.53	0.85	0.56
Price to Earnings (P/E)	0.00	0.00	3.52	17.12	7.84	10.67	14.25
Dividend Yield	0.00%	0.00%	0.00%	0.49%	2.20%	1.91%	3.77%
Earnings Yield	0.00%	0.00%	28.41%	5.84%	12.76%	9.37%	7.02%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.00	1.99	1.68	2.64	1.54
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.85	0.74	0.72	1.01	0.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	5.31	4.07	4.87	6.34	6.23
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	7.35	5.02	6.60	8.61	10.92
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	10.62	6.98	9.63	11.54	16.46
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	4.38	6.15	5.28	8.15	9.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.26	11.19	57.47	8.22	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.01	7.68	1.52	1.06	0.95	0.88
Long-Term Debt to Equity	0.00	0.01	7.46	1.48	1.03	0.92	0.79
Financial Leverage	0.00	-0.03	0.42	1.97	0.86	0.73	0.73
Leverage Ratio	0.00	1.38	2.40	6.17	3.54	3.13	2.96
Compound Leverage Factor	0.00	1.44	2.41	5.38	3.24	2.86	2.48
Debt to Total Capital	0.00%	1.22%	88.48%	60.35%	51.56%	48.70%	46.89%
Short-Term Debt to Total Capital	0.00%	0.19%	2.59%	1.70%	1.51%	1.33%	4.95%
Long-Term Debt to Total Capital	0.00%	1.03%	85.89%	58.66%	50.05%	47.37%	41.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	98.78%	11.52%	39.65%	48.44%	51.30%	53.11%
Debt to EBITDA	0.00	0.12	3.09	1.56	1.76	1.33	2.05
Net Debt to EBITDA	0.00	-0.31	2.74	1.02	1.24	0.99	1.72
Long-Term Debt to EBITDA	0.00	0.10	3.00	1.52	1.71	1.30	1.83
Debt to NOPAT	0.00	0.31	6.18	2.68	3.47	2.43	5.40
Net Debt to NOPAT	0.00	-0.83	5.47	1.74	2.46	1.81	4.55
Long-Term Debt to NOPAT	0.00	0.26	6.00	2.60	3.37	2.36	4.83
Altman Z-Score	0.00	0.00	3.00	3.86	3.65	4.61	3.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	2.28	1.46	1.71	1.72	1.56	1.50
Quick Ratio	0.00	1.46	0.74	1.11	0.93	0.93	0.78
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,960	1,064	241	46	465	-80
Operating Cash Flow to CapEx	455.65%	543.94%	795.65%	293.96%	240.00%	212.22%	119.64%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	3.49	1.36	11.93	-2.05
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	6.35	14.82	12.03	6.87
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	4.19	8.65	6.36	1.13
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	0.82	1.03	1.37	1.33	1.38	1.25
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	5.64	6.90	8.15	7.32	7.41	6.72
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	6.79	6.39	6.24	6.43	7.12	6.92
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	64.71	52.89	44.81	49.90	49.28	54.35
Days Payable Outstanding (DPO)	0.00	53.74	57.14	58.53	56.78	51.28	52.74
Cash Conversion Cycle (CCC)	0.00	10.97	-4.26	-13.73	-6.89	-2.00	1.60
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	2,043	1,205	1,350	1,580	1,446	1,684
Invested Capital Turnover	0.00	2.33	1.74	2.84	2.54	2.49	2.14
Increase / (Decrease) in Invested Capital	0.00	2,043	-838	145	230	-134	238
Enterprise Value (EV)	0.00	0.00	2,404	2,692	2,661	3,821	2,599
Market Capitalization	0.00	0.00	1,165	2,020	1,982	3,222	1,881
Book Value per Share	$0.00	$0.00	$4.13	$15.36	$21.68	$20.65	$24.49
Tangible Book Value per Share	$0.00	$0.00	$1.36	$12.46	$18.34	$17.95	$21.60
Total Capital	0.00	2,138	1,580	1,710	1,860	1,651	1,819
Total Debt	0.00	26	1,398	1,032	959	804	853
Total Long-Term Debt	0.00	22	1,357	1,003	931	782	763
Net Debt	0.00	-69	1,239	672	679	599	718
Capital Expenditures (CapEx)	115	66	69	149	210	221	224
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	538	232	184	246	198	315
Debt-free Net Working Capital (DFNWC)	0.00	633	391	544	526	403	450
Net Working Capital (NWC)	0.00	629	350	515	498	381	360
Net Nonoperating Expense (NNE)	-6.76	-87	-105	268	23	29	26
Net Nonoperating Obligations (NNO)	0.00	-69	1,023	672	679	599	718
Total Depreciation and Amortization (D&A)	192	135	126	125	143	159	179
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	22.56%	8.20%	5.07%	6.61%	5.25%	9.40%
Debt-free Net Working Capital to Revenue	0.00%	26.54%	13.83%	14.99%	14.14%	10.68%	13.43%
Net Working Capital to Revenue	0.00%	26.37%	12.38%	14.20%	13.38%	10.10%	10.74%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$7.53	$2.68	$6.02	$7.35	$3.29
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$7.53	$2.66	$5.93	$7.18	$3.24
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Normalized Net Operating Profit after Tax (NOPAT)	375	83	226	386	276	331	165
Normalized NOPAT Margin	9.33%	3.49%	8.00%	10.63%	7.43%	8.78%	4.93%
Pre Tax Income Margin	12.50%	3.98%	11.60%	12.87%	9.92%	10.73%	5.94%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	7.77	11.85	11.38	6.10
NOPAT to Interest Expense	0.00	0.00	0.00	5.59	8.13	8.49	4.05
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	5.61	5.68	5.72	0.36
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	3.43	1.95	2.82	-1.70
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	8.47%	22.53%	20.53%	55.30%
Augmented Payout Ratio	0.00%	0.00%	0.00%	76.27%	50.20%	43.38%	117.42%

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	39,508,287.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	39,508,287.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.08
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.33%	3.99%	-3.83%	1.52%	7.58%	0.62%	-9.28%	-14.90%	-12.33%	-8.25%	-8.04%
EBITDA Growth	-30.61%	-34.71%	-40.98%	37.07%	36.03%	36.04%	-24.07%	-52.83%	-21.08%	-24.50%	-46.34%
EBIT Growth	-39.39%	-47.48%	-53.38%	48.78%	46.00%	46.58%	-39.13%	-75.41%	-33.56%	-35.51%	-92.86%
NOPAT Growth	-47.91%	-46.75%	-51.43%	56.12%	64.86%	62.34%	-30.51%	-74.89%	-40.21%	-54.70%	-93.89%
Net Income Growth	1.75%	-47.87%	-55.67%	69.39%	63.79%	65.31%	-37.21%	-81.93%	-40.00%	-59.26%	-111.11%
EPS Growth	7.03%	-44.81%	-54.67%	73.68%	65.69%	63.25%	-36.27%	-81.31%	-37.89%	-57.59%	-112.31%
Operating Cash Flow Growth	62.81%	17.61%	-57.14%	49.35%	-17.26%	-1.80%	-14.81%	-44.35%	-46.63%	-42.68%	-143.48%
Free Cash Flow Firm Growth	-185.51%	-294.77%	188.83%	182.26%	108.64%	224.95%	19.26%	-132.71%	-155.82%	-190.06%	-313.18%
Invested Capital Growth	0.00%	17.04%	-1.69%	-10.63%	-1.64%	-8.48%	-3.56%	7.24%	8.75%	16.46%	12.67%
Revenue Q/Q Growth	-2.39%	7.47%	-6.12%	3.09%	3.43%	0.52%	-15.36%	-3.29%	6.55%	5.20%	-15.17%
EBITDA Q/Q Growth	17.24%	-18.38%	-2.70%	47.22%	16.35%	-18.38%	-45.70%	-8.54%	94.67%	-21.92%	-61.40%
EBIT Q/Q Growth	21.95%	-27.00%	-5.48%	76.81%	19.67%	-26.71%	-60.75%	-28.57%	223.33%	-28.87%	-95.65%
NOPAT Q/Q Growth	11.04%	-16.24%	-7.38%	81.21%	17.26%	-17.52%	-60.35%	-34.52%	179.24%	-37.52%	-94.65%
Net Income Q/Q Growth	18.37%	-15.52%	-12.24%	93.02%	14.46%	-14.74%	-66.67%	-44.44%	280.00%	-42.11%	-109.09%
EPS Q/Q Growth	20.18%	-14.60%	-12.82%	94.12%	14.65%	-15.86%	-65.97%	-43.08%	281.08%	-42.55%	-109.88%
Operating Cash Flow Q/Q Growth	155.84%	-15.23%	-83.83%	325.93%	41.74%	0.61%	-85.98%	178.26%	35.94%	8.05%	-110.64%
Free Cash Flow Firm Q/Q Growth	-356.18%	88.36%	143.85%	253.27%	-52.09%	68.35%	-58.14%	-196.90%	18.25%	-171.61%	0.93%
Invested Capital Q/Q Growth	-8.67%	-0.06%	3.10%	-5.03%	0.52%	-7.01%	8.64%	5.60%	1.93%	-0.41%	5.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	25.86%	21.89%	20.88%	26.69%	27.46%	24.43%	19.37%	19.40%	26.24%	22.47%	16.56%
EBITDA Margin	15.16%	11.51%	11.93%	17.04%	19.17%	15.57%	9.99%	9.45%	17.26%	12.81%	5.83%
Operating Margin	11.15%	7.57%	7.62%	13.08%	15.13%	11.03%	5.12%	3.78%	11.47%	7.75%	0.40%
EBIT Margin	11.15%	7.57%	7.62%	13.08%	15.13%	11.03%	5.12%	3.78%	11.47%	7.75%	0.40%
Profit (Net Income) Margin	6.47%	5.08%	4.75%	8.90%	9.84%	8.35%	3.29%	1.89%	6.74%	3.71%	-0.40%
Tax Burden Percent	63.74%	73.13%	71.67%	73.45%	71.97%	81.00%	81.82%	75.00%	64.77%	56.90%	50.00%
Interest Burden Percent	91.00%	91.78%	86.96%	92.62%	90.41%	93.46%	78.57%	66.67%	90.72%	84.06%	-200.00%
Effective Tax Rate	36.26%	26.87%	28.33%	26.55%	28.03%	19.00%	18.18%	25.00%	35.23%	43.10%	0.00%
Return on Invested Capital (ROIC)	33.11%	14.07%	12.26%	21.68%	26.16%	22.28%	9.65%	6.28%	15.70%	9.45%	0.55%
ROIC Less NNEP Spread (ROIC-NNEP)	31.57%	13.42%	11.45%	20.84%	24.68%	21.39%	8.60%	5.22%	14.82%	8.49%	-0.15%
Return on Net Nonoperating Assets (RNNOA)	28.14%	11.48%	10.96%	19.54%	18.97%	15.64%	6.71%	4.13%	10.32%	6.17%	-0.12%
Return on Equity (ROE)	61.25%	25.55%	23.22%	41.21%	45.13%	37.92%	16.37%	10.41%	26.02%	15.62%	0.43%
Cash Return on Invested Capital (CROIC)	-159.14%	3.16%	15.33%	26.86%	20.64%	30.74%	23.34%	8.52%	4.32%	-5.12%	-4.32%
Operating Return on Assets (OROA)	14.75%	10.10%	10.04%	17.54%	20.19%	15.20%	6.96%	5.01%	14.14%	9.68%	0.48%
Return on Assets (ROA)	8.55%	6.78%	6.26%	11.94%	13.14%	11.51%	4.47%	2.50%	8.31%	4.63%	-0.48%
Return on Common Equity (ROCE)	61.25%	25.55%	23.22%	41.21%	45.13%	37.92%	16.37%	10.41%	26.02%	15.62%	0.43%
Return on Equity Simple (ROE_SIMPLE)	35.65%	0.00%	22.38%	28.07%	28.82%	0.00%	31.50%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	64	53	49	90	105	87	34	23	63	39	2.10
NOPAT Margin	7.11%	5.54%	5.46%	9.60%	10.89%	8.94%	4.19%	2.83%	7.43%	4.41%	0.28%
Net Nonoperating Expense Percent (NNEP)	1.54%	0.65%	0.80%	0.83%	1.48%	0.89%	1.05%	1.06%	0.88%	0.95%	0.70%
Return On Investment Capital (ROIC_SIMPLE)	-	2.87%	-	-	-	5.25%	1.99%	1.27%	3.52%	2.16%	0.11%
Cost of Revenue to Revenue	74.14%	78.11%	79.12%	73.31%	72.54%	75.57%	80.63%	80.60%	73.76%	77.53%	83.44%
SG&A Expenses to Revenue	9.92%	9.96%	8.18%	8.79%	7.67%	8.35%	8.89%	9.07%	8.04%	7.64%	9.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.72%	14.32%	13.26%	13.61%	12.33%	13.40%	14.25%	15.62%	14.78%	14.72%	16.16%
Earnings before Interest and Taxes (EBIT)	100	73	69	122	146	107	42	30	97	69	3.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	136	111	108	159	185	151	82	75	146	114	44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.12	2.20	2.85	3.38	3.74	3.80	2.97	2.11	1.81	1.95	1.69
Price to Tangible Book Value (P/TBV)	2.53	2.60	3.36	3.95	4.31	4.38	3.42	2.43	2.08	2.21	1.92
Price to Revenue (P/Rev)	0.48	0.53	0.69	0.76	0.93	0.85	0.73	0.57	0.52	0.56	0.50
Price to Earnings (P/E)	5.95	7.84	12.74	12.03	12.97	10.67	9.44	9.28	9.82	14.25	16.19
Dividend Yield	2.04%	2.20%	1.80%	1.69%	1.58%	1.91%	2.48%	3.62%	4.11%	3.77%	4.31%
Earnings Yield	16.81%	12.76%	7.85%	8.31%	7.71%	9.37%	10.60%	10.78%	10.18%	7.02%	6.18%
Enterprise Value to Invested Capital (EV/IC)	1.59	1.68	2.01	2.27	2.65	2.64	2.14	1.64	1.47	1.54	1.38
Enterprise Value to Revenue (EV/Rev)	0.68	0.72	0.89	0.95	1.09	1.01	0.91	0.77	0.72	0.78	0.74
Enterprise Value to EBITDA (EV/EBITDA)	4.16	4.87	6.95	6.85	7.32	6.34	5.83	5.52	5.47	6.23	6.44
Enterprise Value to EBIT (EV/EBIT)	5.37	6.60	10.11	9.67	10.05	8.61	8.06	8.38	8.99	10.92	12.27
Enterprise Value to NOPAT (EV/NOPAT)	7.79	9.63	14.63	13.73	13.84	11.54	10.65	10.95	12.04	16.46	19.25
Enterprise Value to Operating Cash Flow (EV/OCF)	5.26	5.28	7.00	6.95	8.73	8.15	7.23	6.58	7.34	9.70	10.39
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	57.47	13.00	7.99	12.73	8.22	9.00	19.93	35.38	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.20	1.06	1.07	1.11	0.99	0.95	0.90	0.85	0.83	0.88	0.94
Long-Term Debt to Equity	1.13	1.03	1.04	1.08	0.94	0.92	0.87	0.80	0.80	0.79	0.78
Financial Leverage	0.89	0.86	0.96	0.94	0.77	0.73	0.78	0.79	0.70	0.73	0.77
Leverage Ratio	3.33	3.54	3.33	3.26	3.18	3.13	3.02	3.00	2.91	2.96	2.90
Compound Leverage Factor	3.03	3.24	2.90	3.02	2.88	2.93	2.37	2.00	2.64	2.49	-5.79
Debt to Total Capital	54.44%	51.56%	51.63%	52.63%	49.70%	48.70%	47.36%	45.88%	45.27%	46.89%	48.47%
Short-Term Debt to Total Capital	2.89%	1.51%	1.52%	1.60%	2.31%	1.33%	1.33%	2.60%	1.68%	4.95%	8.16%
Long-Term Debt to Total Capital	51.55%	50.05%	50.11%	51.03%	47.40%	47.37%	46.03%	43.28%	43.59%	41.95%	40.32%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	45.56%	48.44%	48.37%	47.37%	50.30%	51.30%	52.64%	54.12%	54.73%	53.11%	51.53%
Debt to EBITDA	1.65	1.76	2.01	1.79	1.64	1.33	1.42	1.65	1.78	2.05	2.43
Net Debt to EBITDA	1.23	1.24	1.57	1.39	1.10	0.99	1.15	1.42	1.57	1.72	2.09
Long-Term Debt to EBITDA	1.56	1.71	1.96	1.74	1.57	1.30	1.38	1.56	1.71	1.83	2.02
Debt to NOPAT	3.09	3.47	4.24	3.60	3.11	2.43	2.59	3.27	3.92	5.40	7.26
Net Debt to NOPAT	2.31	2.46	3.31	2.80	2.08	1.81	2.10	2.82	3.46	4.55	6.24
Long-Term Debt to NOPAT	2.93	3.37	4.11	3.49	2.97	2.36	2.52	3.09	3.77	4.83	6.04
Altman Z-Score	3.31	3.27	3.52	3.83	3.96	4.18	3.89	3.52	3.45	3.35	3.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.76	1.72	1.72	1.68	1.72	1.56	1.64	1.54	1.52	1.50	1.45
Quick Ratio	0.92	0.93	0.87	0.85	0.96	0.93	0.93	0.78	0.75	0.78	0.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,517	-177	77	274	131	221	92	-90	-73	-199	-197
Operating Cash Flow to CapEx	469.05%	265.08%	45.00%	216.98%	370.45%	256.25%	47.92%	96.97%	161.11%	167.86%	-20.41%
Free Cash Flow to Firm to Interest Expense	-168.58	-29.44	8.61	30.40	9.36	31.52	10.26	-8.95	-8.13	-18.07	-21.88
Operating Cash Flow to Interest Expense	21.89	27.83	3.00	12.78	11.64	23.43	2.56	6.40	9.67	8.55	-1.11
Operating Cash Flow Less CapEx to Interest Expense	17.22	17.33	-3.67	6.89	8.50	14.29	-2.78	-0.20	3.67	3.45	-6.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.32	1.33	1.32	1.34	1.33	1.38	1.36	1.32	1.23	1.25	1.20
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	5.94	7.32	6.25	6.28	6.51	7.41	7.13	6.77	6.22	6.72	6.04
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	7.09	6.43	7.02	7.23	7.48	7.12	7.04	7.20	6.96	6.92	6.52
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	61.44	49.90	58.36	58.16	56.10	49.28	51.16	53.92	58.68	54.35	60.39
Days Payable Outstanding (DPO)	51.47	56.78	51.97	50.51	48.81	51.28	51.88	50.71	52.44	52.74	56.01
Cash Conversion Cycle (CCC)	9.97	-6.89	6.39	7.64	7.29	-2.00	-0.72	3.20	6.25	1.60	4.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,581	1,580	1,629	1,547	1,555	1,446	1,571	1,659	1,691	1,684	1,770
Invested Capital Turnover	4.66	2.54	2.24	2.26	2.40	2.49	2.31	2.21	2.11	2.14	1.97
Increase / (Decrease) in Invested Capital	1,581	230	-28	-184	-26	-134	-58	112	136	238	199
Enterprise Value (EV)	2,518	2,661	3,276	3,519	4,119	3,821	3,361	2,722	2,481	2,599	2,442
Market Capitalization	1,773	1,982	2,536	2,802	3,501	3,222	2,698	2,022	1,767	1,881	1,651
Book Value per Share	$19.97	$21.68	$21.62	$20.18	$22.85	$20.65	$22.39	$23.55	$24.20	$24.49	$24.78
Tangible Book Value per Share	$16.77	$18.34	$18.36	$17.24	$19.80	$17.95	$19.46	$20.46	$21.03	$21.60	$21.72
Total Capital	1,835	1,860	1,838	1,752	1,863	1,651	1,725	1,772	1,785	1,819	1,900
Total Debt	999	959	949	922	926	804	817	813	808	853	921
Total Long-Term Debt	946	931	921	894	883	782	794	767	778	763	766
Net Debt	745	679	740	717	618	599	663	700	714	718	791
Capital Expenditures (CapEx)	42	63	60	53	44	64	48	66	54	56	49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	311	246	285	269	250	198	264	275	273	315	364
Debt-free Net Working Capital (DFNWC)	565	526	494	474	558	403	418	388	367	450	494
Net Working Capital (NWC)	512	498	466	446	515	381	395	342	337	360	339
Net Nonoperating Expense (NNE)	5.74	4.39	6.45	6.61	10	5.67	7.36	7.50	5.83	6.26	5.10
Net Nonoperating Obligations (NNO)	745	679	740	717	618	599	663	700	714	718	791
Total Depreciation and Amortization (D&A)	36	38	39	37	39	44	40	45	49	45	41
Debt-free, Cash-free Net Working Capital to Revenue	8.44%	6.61%	7.73%	7.27%	6.64%	5.25%	7.16%	7.75%	7.96%	9.40%	11.08%
Debt-free Net Working Capital to Revenue	15.34%	14.14%	13.41%	12.81%	14.81%	10.68%	11.33%	10.93%	10.70%	13.43%	15.04%
Net Working Capital to Revenue	13.90%	13.38%	12.65%	12.06%	13.67%	10.10%	10.71%	9.63%	9.82%	10.74%	10.32%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.39	$1.19	$1.04	$2.02	$2.32	$1.97	$0.66	$0.37	$1.43	$0.83	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Adjusted Diluted Earnings per Share	$1.37	$1.17	$1.02	$1.98	$2.27	$1.91	$0.65	$0.37	$1.41	$0.81	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	41.55M	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M
Normalized Net Operating Profit after Tax (NOPAT)	64	53	49	90	105	87	34	23	63	39	2.10
Normalized NOPAT Margin	7.11%	5.54%	5.46%	9.60%	10.89%	8.94%	4.19%	2.83%	7.43%	4.41%	0.28%
Pre Tax Income Margin	10.14%	6.95%	6.63%	12.11%	13.68%	10.31%	4.02%	2.52%	10.40%	6.52%	-0.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.11	12.17	7.67	13.56	10.43	15.29	4.67	3.00	10.78	6.27	0.33
NOPAT to Interest Expense	7.08	8.90	5.49	9.96	7.51	12.38	3.82	2.25	6.98	3.57	0.23
EBIT Less CapEx to Interest Expense	6.44	1.67	1.00	7.67	7.29	6.14	-0.67	-3.60	4.78	1.18	-5.11
NOPAT Less CapEx to Interest Expense	2.42	-1.60	-1.17	4.07	4.36	3.24	-1.52	-4.35	0.98	-1.52	-5.21
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.42%	22.53%	29.65%	26.18%	25.19%	20.53%	23.78%	33.49%	41.11%	55.30%	71.57%
Augmented Payout Ratio	57.05%	50.20%	62.31%	51.93%	42.59%	43.38%	53.15%	69.72%	108.33%	117.42%	132.35%

Financials Breakdown Chart

Key Financial Trends

Sylvamo Corp (NYSE: SLVM) has shown improving operating cash flow in 2025, but top‑line strength and earnings have remained uneven across quarters. Below is a concise, data‑driven snapshot of the last four years of quarterly statements, focused on the most meaningful trends for retail investors.

Cash from operations improving in 2025: Net cash from continuing operating activities rose through 2025, hitting $94 million in Q4 2025 (vs. $87m in Q3, $64m in Q2, and $33m in Q1 2025).
Solid free cash flow in the latest quarter: Q4 2025 free cash flow was about $38 million (CFO of $94m minus capex of $56m), indicating cash available after sustaining investments.
Financing activity turned modestly positive in Q4 2025: Net cash from financing activities was +$3 million in Q4 2025, after several quarters of net debt outflows (Q1–Q3 2025 all negative).
Quarterly earnings per share remained positive in Q4 2025: Basic EPS was $0.83 and Diluted EPS was $0.81, signaling ongoing profitability on a per‑share basis.
Top‑line softness in Q4 2025: Operating revenue for Q4 2025 was $890 million, down from $970 million in Q4 2024 (seasonality and mix may explain some pressure).
Stable balance sheet presence: Total assets around $2.7B and total liabilities about $1.7B in the latest period, indicating a fairly steady capitalization profile.
Material year‑over‑year earnings decline in Q4 2025: Net income attributable to common shareholders dropped to $33 million in Q4 2025 from $81 million in Q4 2024.
EPS dragged lower in Q4 2025: Diluted EPS at $0.81 (vs. higher prior-year levels), reflecting ongoing earnings pressure despite positive cash flow.
Ongoing cash outflows for share repurchases in 2024–2025: Notable buybacks occurred in prior periods (e.g., Q3 2025 repurchase of $42 million; Q2 2025 around $20 million; Q4 2024 around $28.8 million), which reduced available cash for other uses.
Gross margin pressure in Q4 2025: Gross margin in Q4 2025 was about 22.5% (200m gross profit on 890m revenue), lower than the roughly 26% margin seen in Q3 2025 (222m on 846m), signaling cost or mix headwinds.

05/15/26 12:48 AM ETAI Generated. May Contain Errors.

Sylvamo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sylvamo's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Sylvamo's net income appears to be on a downward trend, with a most recent value of $132 million in 2025, falling from $377 million in 2019. The previous period was $302 million in 2024. Check out Sylvamo's forecast to explore projected trends and price targets.

Sylvamo's total operating income in 2025 was $238 million, based on the following breakdown:

Total Gross Profit: $735 million
Total Operating Expenses: $497 million

Over the last 6 years, Sylvamo's total revenue changed from $4.02 billion in 2019 to $3.35 billion in 2025, a change of -16.6%.

Sylvamo's total liabilities were at $1.80 billion at the end of 2025, a 2.3% increase from 2024, and a 124.9% increase since 2020.

In the past 5 years, Sylvamo's cash and equivalents has ranged from $95 million in 2020 to $360 million in 2022, and is currently $135 million as of their latest financial filing in 2025.

Over the last 6 years, Sylvamo's book value per share changed from 0.00 in 2019 to 24.49 in 2025, a change of 2,449.4%.

Related Companies

Financial statements for NYSE:SLVM last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sylvamo (SLVM) Financials

Financials Breakdown Chart

Key Financial Trends

Sylvamo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sylvamo (SLVM) Financials

Annual Income Statements for Sylvamo

Quarterly Income Statements for Sylvamo

Annual Cash Flow Statements for Sylvamo

Quarterly Cash Flow Statements for Sylvamo

Annual Balance Sheets for Sylvamo

Quarterly Balance Sheets for Sylvamo

Annual Metrics And Ratios for Sylvamo

Quarterly Metrics And Ratios for Sylvamo

Financials Breakdown Chart

Key Financial Trends

Sylvamo Financials - Frequently Asked Questions

When does Sylvamo's financial year end?

How has Sylvamo's net income changed over the last 6 years?

What is Sylvamo's operating income?

How has Sylvamo's revenue changed over the last 6 years?

How much debt does Sylvamo have?

How much cash does Sylvamo have?

How has Sylvamo's book value per share changed over the last 6 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools